Eton Pharmaceuticals, Inc. (NASDAQ:ETON) has received FDA approval for KHINDIVI, the first and only hydrocortisone oral solution available in the United States, marking a major milestone for ...

Eton Pharmaceuticals (NASDAQ:ETON) traded higher in the premarket on Thursday after the U.S. FDA approved its oral hydrocortisone solution Khindivi as a replacement therapy for children with ...

Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA) approval as a replacement therapy for ...

Also Read: Eton Pharma Plans FDA Filing For ET-600 Oral Desmopressin Next Month, Eyes 2026 Launch Cortisol helps break down fats, proteins and carbohydrates in the body. Khindivi comes in a 1mg/ml ...

Investing.com -- Shares of Eton Pharmaceuticals Inc (NASDAQ:ETON) climbed 3.3% premarket following the announcement that the U.S. Food and Drug Administration (FDA) approved KHINDIVI ...

Investing.com -- Shares of Eton Pharmaceuticals Inc (NASDAQ:ETON) climbed 3.3% premarket following the announcement that the U.S. Food and Drug Administration (FDA) approved KHINDIVI™ (hydrocortisone) ...

Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced the US Food and Drug Administration (FDA) approval of ...

Eton Pharmaceuticals reported a robust first quarter for 2025, with revenue far surpassing expectations. The company achieved a revenue of $17.3 million, marking a 117% increase from the same ...

• Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocortisone) oral granules to exceed $50 million DEER PARK, Ill., May 28, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals ...

Eton Pharmaceuticals ETON is preparing to release its quarterly earnings on Tuesday, 2025-05-13. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

DEER PARK, Ill., May 28, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...